Late-Breaking Data Confirms Safety of Axon Therapies’ Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy

Posted on by

REBALANCE-HF early feasibility trial met objective of identifying responder group with demonstrated benefits in heart function, hemodynamics, and physical activity at 6 months SAVM procedure quick and easy to perform with high success rate and no significant increase in procedure-related…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.